Clinical Trial: A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: A Phase I Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron (CYCLOTEC) in Patients With Thyroid Scan Indication
Brief Summary: Prospective, open label single site study to demonstrate the safety and efficacy of Tc-99m pertechnetate produced by high energy cyclotron at CHUS.
Detailed Summary: The proposed clinical trial will be a prospective, case-controlled Phase I, open label, single site study. The first 10 consecutively enrolled patients will receive CYCLOTEC standard procedure thyroid imagery and an additional whole-body scans, and 20 subsequent case-matched controls, will receive GPERT and will also have additionnal whole body scan.
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Current Primary Outcome: Biodistribution of Tc99m produced by high-energy cyclotron (CycloTec) [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Dates:
Date Received: September 24, 2014
Date Started: September 2014
Date Completion: December 2016
Last Updated: April 5, 2016
Last Verified: April 2016